1/13
10:15 am
lpaa
Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform
Low
Report
Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform
1/13
09:51 am
lpaa
Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform
Low
Report
Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform
1/13
04:05 am
lpaa
Launch One Acquisition (NASDAQ:LPAA) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Launch One Acquisition (NASDAQ:LPAA) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
11/20
08:30 am
lpaa
Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition
Low
Report
Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition
11/20
08:30 am
lpaa
Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition
Low
Report
Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition